Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $1,702 - $2,392
40 Added 0.64%
6,325 $357,000
Q4 2023

Feb 14, 2024

SELL
$32.18 - $46.57 $306,063 - $442,927
-9,511 Reduced 60.21%
6,285 $282,000
Q2 2023

Aug 14, 2023

SELL
$31.86 - $67.26 $17,682 - $37,329
-555 Reduced 3.39%
15,796 $684,000
Q1 2023

May 12, 2023

SELL
$45.44 - $74.26 $26,264 - $42,922
-578 Reduced 3.41%
16,351 $1.07 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $26,199 - $51,273
633 Added 3.88%
16,929 $761,000
Q3 2022

Nov 08, 2022

BUY
$72.36 - $113.1 $8,683 - $13,572
120 Added 0.74%
16,296 $1.18 Million
Q2 2022

Aug 08, 2022

BUY
$87.2 - $114.05 $607,435 - $794,472
6,966 Added 75.64%
16,176 $1.74 Million
Q1 2022

May 17, 2022

BUY
$94.19 - $124.49 $486,114 - $642,492
5,161 Added 127.46%
9,210 $1.02 Million
Q4 2021

Feb 15, 2022

BUY
$119.57 - $139.07 $329,654 - $383,415
2,757 Added 213.39%
4,049 $518,000
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $30,458 - $39,715
279 Added 27.54%
1,292 $172,000
Q2 2021

Jul 30, 2021

BUY
$100.34 - $115.69 $38,229 - $44,077
381 Added 60.28%
1,013 $110,000
Q1 2021

May 07, 2021

BUY
$101.51 - $125.27 $46,085 - $56,872
454 Added 255.06%
632 $67,000
Q4 2020

Feb 12, 2021

BUY
$85.88 - $105.36 $15,286 - $18,754
178 New
178 $19,000
Q2 2019

Aug 14, 2019

SELL
$39.26 - $54.21 $45,266 - $62,504
-1,153 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$29.84 - $43.92 $34,226 - $50,376
-1,147 Reduced 49.87%
1,153 $47,000
Q4 2018

Jan 31, 2019

SELL
$29.95 - $46.34 $23,900 - $36,979
-798 Reduced 25.76%
2,300 $72,000
Q3 2018

Nov 15, 2018

SELL
$40.12 - $45.55 $81,403 - $92,420
-2,029 Reduced 39.57%
3,098 $141,000
Q2 2018

Aug 22, 2018

BUY
$38.72 - $42.52 $145,238 - $159,492
3,751 Added 272.6%
5,127 $215,000
Q2 2018

Aug 15, 2018

SELL
$38.72 - $42.52 $240,606 - $264,219
-6,214 Reduced 81.87%
1,376 $215,000
Q1 2018

May 15, 2018

SELL
$39.4 - $47.39 $34,435 - $41,418
-874 Reduced 10.33%
7,590 $317,000
Q4 2017

Feb 13, 2018

SELL
$37.27 - $43.02 $78,863 - $91,030
-2,116 Reduced 20.0%
8,464 $348,000
Q3 2017

Nov 07, 2017

BUY
$33.75 - $41.67 $357,075 - $440,868
10,580
10,580 $422,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.